Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata

Neuroscience

Volumn 80, Issue 1, 1997, Pages 241-249

  Garcia, M ^a   Floran, B ^a   Arias Montano J A ^a   Young, J M ^b   Aceves, J ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

3H dopamine release; 3H GABA release; Dopamine D1 receptor; Histamine H3 receptor; Immepip; Substantia nigra pars reticulata

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; HISTAMINE; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR AGONIST; POTASSIUM ION; RESERPINE; SULPIRIDE; THIOPERAMIDE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; POTASSIUM;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RADIOASSAY; WISTAR RAT;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; HISTAMINE; MALE; NEUROTRANSMITTER AGENTS; POTASSIUM; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, HISTAMINE H3; SUBSTANTIA NIGRA;

EID: 0030610371     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00100-0     Document Type: Article

References (37)

1. Aceves J. and Cuello A. C. (1981) Dopamine release induced by electrical stimulation of microdissected caudate-putamen and substantia nigra. Neuroscience 6, 2069-2075.
2. Arias-Montaño J. A., Martinez-Fong D. and Aceves J. (1992) Glutamate stimulation of tyrosine hydroxylase is mediated by NMDA receptors in the rat striatum. Brain Res. 569, 317-322.
3. 3 receptors regulating acetylcholine release in rat entorhinal cortex. Br. J. Pharmac. 114, 1518-1522.
4. 3 receptors. Nature 327, 117-123.
5. 3) of histamine receptor. Nature 302, 832-837.
6. 1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 348, 239-242.
7. Barone P., Tucci I., Sotirios A. P. and Chase T. N. (1987) D-1 dopamine receptor changes after striatal quinolinic acid lesion. Eur. J. Pharmac. 138, 141-145.
8. Cheramy A., Leviel V. and Glowinski J. (1981) Dendritic release of dopamine in the substantia nigra. Nature 289, 537-542.
9. 3 receptor subtypes. Br. J. Pharmac. 107, 919-923.
10. 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur. J. Pharmac. 259, 107-114.
11. 35S]GTPγS binding to pertussis toxin. Eur. J. Pharmac. 296, 223-225.
12. 3 receptor: characterisation and autoradiographic localization in rat brain. Synapse 8, 144-151.
13. 3 binding in rat forebrain after reserpine treatment. Brain Res. 602, 53-56.
14. 1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci. Lett. 116, 136-140.
15. 2+ channels are involved in acetylcholine release at a neuronal synapse: only the N-type channel is the target of neuromodulators. Proc. natn. Acad. Sci. U.S.A. 91, 4771-4775.
16. 3H]γ-aminobutyric acid in the rat neostriatum - II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen. Neuroscience 19, 1109-1117.
17. 3H]γ-aminobutyric acid in the rat neostriatum - I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents. Neuroscience 19, 1101-1108.
18. Heeringa M. J. and Abercrombie E. D. (1995) Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J. Neurochem. 65, 192-200.
19. Inagaki N., Yamatodani A., Ando-Yamamoto M., Tohyama M., Watanabe T. and Wada H. (1988) Organization of histaminergic fibres in the rat brain. J. comp. Neurol. 273, 283-300.
20. Iravani M. M., Muscat R. and Kruk Z. L. (1996) Comparison of somatodendritic and axon terminal release in the ventral tegmental area and the nucleus accumbens. Neuroscience 70, 1025-1037.
21. Leurs R., Smit M. J. and Timmerman H. (1995) Molecular pharmacological aspects of histamine receptors. Pharmac. Ther. 66, 413-463.
22. 3 receptor revealed. Br. J. Pharmac. 116, 2315-2321.
23. 3 receptors. J. Pharmac. exp. Ther. 271, 452-459.
24. Mons N. and Cooper D. M. F. (1995) Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci. 18, 536-542.
25. 3H]histamine in rat brain by reserpine. Eur. J. Pharmac. 24, 399-401.
26. 3 receptors in rat brain areas. Neuroscience 52, 169-189.
27. Reimann W., Zumstein A. and Starke K. (1982) γ-aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit. J. Neurochem. 39, 961-969.
28. Rubinstein M., Muschietti J. P., Gershanil O., Flawia M. M. and Stefano F. J. E. (1990) Adaptive mechanisms of striatal D1 and D2 dopamine receptors to prolonged reserpine treatment in mice. J. Pharmac. exp. Ther. 252, 810-816.
29. Ryu J. H., Yanai K., Iwata R., Ido T. and Watanabe T. (1994) Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat brain. NeuroReport 5, 621-624.
30. 3-receptors following destruction of the ascending dopaminergic neurones. Br. J. Pharmac. 118, 585-592.
31. 3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn-Schmiedeberg's Arch. Pharmac. 345, 489-493.
32. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch. Pharmac. 337, 588-590.
33. 3 receptors. J. neural Transm. 93, 1-10.
34. 3 receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 340, 633-638.
35. Smits R. P. J. M. and Mulder A. H. (1991) Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochem. Int. 18, 215-220.
36. 1 agonist SKF 38393 increases the state of phosphorylation of ARPP-21 in substantia nigra. J. Neurochem. 60, 1043-1046.
37. 3 receptor agonist, 4-(1H-imidazol-4-ylmethyl)piperidine. J. med. Chem. 37, 332-333.